Kidney damage in COVID-19

被引:3
|
作者
Burtey, Stephane [1 ,2 ]
Sallee, Marion [1 ,2 ]
机构
[1] Aix Marseille Univ, INSERM, INRAE, C2VN, F-13005 Marseille, France
[2] Aix Marseille Univ, Ctr Nephrol & Transplantat Renale, Hop Concept, 147 Blvd Baille, F-13005 Marseille, France
来源
NEPHROLOGIE & THERAPEUTIQUE | 2021年 / 17卷 / 04期
关键词
Acute tubular necrosis; COVID-19; Focal segmental glomerulosclerosis; Proximal tubulopathy; SARS-CoV-2; CORONAVIRUS; TRANSMISSION; INJURY;
D O I
10.1016/j.nephro.2021.06.002
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
COVID-19 is a disease caused by the RNA virus SARS-CoV-2. It is characterised by an attack mainly affecting the respiratory system. There is renal involvement which is characterised by three main types of damage, acute tubular necrosis occurring in the most severe cases, proximal tubulopathy which is a prognostic marker of the disease and segmental and focal hyalinosis occurring in a genetically predisposed terrain. The pathophysiology of SARS-CoV-2 renal involvement is not yet defined. The direct role of the virus is debated, whereas the cytokine storm and the hypoxic and thrombotic complications seem more important. The long-term outcome of the renal damage appears to be quite good. Long-term follow-up will allow us to say whether the renal damage is part of the long COVID. (C) 2021 Societe francophone de nephrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:203 / 207
页数:5
相关论文
共 50 条
  • [21] Kidney Biopsy Findings in Patients with COVID-19
    Kudose, Satoru
    Batal, Ibrahim
    Santoriello, Dominick
    Xu, Katherine
    Barasch, Jonathan
    Peleg, Yonatan
    Canetta, Pietro
    Ratner, Lloyd E.
    Marasa, Maddalena
    Gharavi, Ali G.
    Stokes, M. Barry
    Markowitz, Glen S.
    D'Agati, Vivette D.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (09): : 1959 - 1968
  • [22] Assessment of Kidney Involvement in COVID-19 Patient
    Choudhary, Rajkamal
    Pervez, Anjum
    Kumar, Brajesh
    Patel, Udit Shankar Singh
    Verma, Vinay Kumar
    Ojha, Shubham
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
  • [23] COVID-19 and Kidney Disease: A Clinical Perspective
    Theofilis, Panagiotis
    Vordoni, Aikaterini
    Kalaitzidis, Rigas G.
    CURRENT VASCULAR PHARMACOLOGY, 2022, 20 (04) : 321 - 325
  • [24] COVID-19 and the Invisible Damage
    de Melo, Renato Bessa
    Tavares, Nuno Teixeira
    Duarte, Raquel
    ACTA MEDICA PORTUGUESA, 2020, 33 (05): : 293 - 294
  • [25] COVID-19 and kidney transplantation
    Caillard, Sophie
    PRESSE MEDICALE, 2022, 51 (04): : 104146
  • [26] Kidney Disease and Viral Infection in COVID-19: Why Are Kidney Organoid and Biopsy Studies Not in Agreement?
    Nicosia, Roberto F. F.
    NEPHRON, 2023, 147 (08) : 458 - 464
  • [27] The cognitive consequences of the COVID-19 epidemic: collateral damage?
    Ritchie, Karen
    Chan, Dennis
    Watermeyer, Tam
    BRAIN COMMUNICATIONS, 2020, 2 (02)
  • [28] Gastrointestinal Symptoms and Liver Damage in Patients with COVID-19
    Alay, Handan
    Kesmez Can, Fatmaz
    Yilmaz, Sinan
    Albayrak, Ayse
    Ozkurt, Zulal
    Ozden, Kemalettin
    Parlak, Emine
    Tekin, Erdal
    Kocak, Abdullah Osman
    FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2021, 26 (02): : 249 - 256
  • [29] COVID-19 and The Invisible Damage: The Role of The Family Physician
    Gouveia, Maria
    ACTA MEDICA PORTUGUESA, 2020, 33 (7-8):
  • [30] COVID-19 and the kidney: time to take a closer look
    Liakopoulos, Vassilios
    Roumeliotis, Stefanos
    Papachristou, Stella
    Papanas, Nikolaos
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (05) : 1053 - 1057